Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 9Fatigue 8Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Hodgkin Disease 5Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Sleep Wake Disorders 3Sezary Syndrome 3Sexual Dysfunction, Physiological 3Sarcoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Prolymphocytic 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Mast-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Large Granular Lymphocytic 3Leukemia, Hairy Cell 3

Interventions

Therapeutics 1Surgical Procedures, Operative 1Sclerotherapy 1Risk Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphatic Abnormalities × Therapeutics × Clear all
NCT00866827 2019-01-11

Airway Vascular Lesions

University of Arkansas

Completed
75 enrolled

Hemangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡